SR9009 Injectable

Buy SR9009 Injectable Online

SR9009 is a synthetic REV-ERB agonist best known for preclinical research into circadian regulation, metabolism, inflammation, and exercise-related signaling. Injectable presentation does not establish human clinical use or a validated injectable dosing protocol. The term “SR9009 injectable” refers to a marketed formulation of SR9009; it does not represent an established human injectable medicine or standardized clinical formulation.

Product Information

SR9009 activates REV-ERB nuclear receptors involved in the molecular circadian clock and metabolic gene regulation. Research has predominantly used experimental animal administration rather than established human injectable therapy.

How It Works

SR9009 activates REV-ERBα/β and modifies transcription of genes involved in circadian and metabolic pathways. This can produce broad downstream effects on energy metabolism and inflammatory signaling.

POTENTIAL BENEFITS

1. REV-ERB Research

SR9009 is a useful pharmacological tool for investigating the biological functions of REV-ERB receptors and their role in circadian regulation.

2. Metabolic Research

Animal studies have investigated SR9009 in relation to glucose handling, lipid metabolism, energy expenditure, and metabolic disease models.

3. Exercise-Tolerance Research

Experimental research has reported changes in exercise tolerance in animals following REV-ERB activation, supporting continued investigation of circadian-metabolic control of physical performance.

4. Inflammatory Pathway Research

SR9009 has been studied in models of inflammation, including experimental work involving NLRP3 and other immune-signaling pathways.

Dosage

There is no established human injectable dosage for SR9009. Published experimental studies use animal doses and administration schedules that cannot be directly translated into a safe human protocol. The injectable formulation should therefore not be treated as clinically validated.

Side Effects

Human safety data are limited. Potential concerns include disruption of circadian signaling, metabolic effects, cardiovascular effects, and unpredictable consequences of altering REV-ERB activity systemically.

References

1. PubMed — SR9009 and REV-ERB pharmacology
2. PubMed — SR9009 and exercise/metabolic pathways
3. PubMed — SR9009 and cardiac research
4. PubMed — SR9009 and inflammatory signaling

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.